Stocks and InvestingStocks and Investing
Thu, August 19, 2021
Wed, August 18, 2021
Tue, August 17, 2021
Mon, August 16, 2021

Andrew Fein Maintained (APRE) at Hold with Decreased Target to $80 on, Aug 16th, 2021


Published on 2024-10-27 17:40:03 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Aprea Therapeutics, Inc." (APRE) at Hold with Decreased Target from $120 to $80 on, Aug 16th, 2021.

Andrew has made no other calls on APRE in the last 4 months.



There are 2 other peers that have a rating on APRE. Out of the 2 peers that are also analyzing APRE, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gregory Renza of "RBC Capital" Maintained at Hold with Decreased Target to $100 on, Friday, August 13th, 2021


This is the rating of the analyst that currently disagrees with Andrew


  • Jeffrey Hung of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $60 on, Friday, August 13th, 2021